title: Words of Wisdom. Re: randomized phase III trial on gemcitabine versus mytomicin in recurrent superficial bladder cancer: evaluation of efficacy and tolerance.
authors.affiliation: Institute of Urologic Oncology, Department of Urology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, USA.
authors.forename: Edward N
authors.initials: EN
authors.lastname: Rampersaud
authors.forename: Arie S
authors.initials: AS
authors.lastname: Belldegrun